Please login to the form below
EU
This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
CRUK forges £30m ‘post-Brexit’ R&D alliance
As the UK and EU work to form a new relationship after Brexit, the awards are an example of how funding organisations are seeking to continue to collaborate post-Brexit to ... Research must be prioritised as the UK builds a new relationship with the EU,
Latest news
-
NHS wins legal fight with pharma over off-label Avastin
Lucentis and Bayer’s Eylea, claiming that it contravened broke EU and UK laws governing medicines licensing. ... As we exit the EU and the UK Government is looking for regulatory co-operation between the UK and the EU, this confusion is deeply unhelpful
-
‘Streamlined’ medicines regulation promised in ‘No Deal’ Brexit scenario
patients can access new and innovative medicines at the same time as EU patients.”. ... The final Brexit outcome depends on political decisions in London, Brussels and other EU capitals.
-
Shire’s bleeding disorder drug approved in Europe
Administered as an injection, the drug is now the first and only recombinant von Willbrand Factor (rVWF) treatment approved in the EU that specifically treats the primary deficiency of VWF, one ... VWD is the most common inherited bleeding disorder,
-
Gilead optimistic about Yescarta deal in UK
When NICE gave a rapid ‘no’to Yescarta on 28 August, just one day after it gained EU-wide marketing approval, some commentators concluded England’s cost-effectiveness watchdog was displaying
-
Dismay as NICE rejects Roche’s MS drug Ocrevus
Ocrevus became the first and only drug to be approved in the EU for PPMS in January on the strength of the ORATORIO study which showed it slowed disability progression by
More from news
Approximately 117 fully matching, plus 1,277 partially matching documents found.
Latest Intelligence
-
Cancer immunotherapy: What's on the horizon?
EU and others in China and Eastern Europe – have reached the market.
-
Bluebird Bio: on the cusp of a gene therapy revolution
Bluebird are also likely to get the chance to benchmark their price against Spark’s Luxturna which is on course to gain EU approval by the end of 2019. ... Spark's Luxturna: already approved in the US, expected to gain EU approval by late 2018.
-
Happy 70th birthday NHS: the next 70 need to be very different
This still leaves it in line with an unweighted EU-15 average of 9.8% of national income, but far behind countries such as the US (16.9%), Japan (11.2%), ... EU contributions.
-
Changes to look out for in Medical Devices Regulations
In April 2017 the new EU Medical Devices Regulation and the EU in vitro Diagnostics Regulation (together, the ‘Regulations’) were adopted by the European Parliament, entering into force on 25 May ... Entities outside of the EU will need authorised
-
Protecting patient privacy
With the EU’s new General Data Protection Regulation (GDPR) now imminent, the impetus for life science firms to cement their data management strategies has further increased.
More from intelligence
Approximately 7 fully matching, plus 148 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications.
-
Trio of senior hires joins Syneos Health
the agency and will serve as the head of integrated communications for the EU, partnering with the firm’s customers who work with Syneos for their marketing communications campaigns.
-
Hanover Brussels appoints Aurélie Marchand as account director
Hanover Brussels has bolstered its policy team with a new senior hire in the form of Aurélie Marchand, who joins the communications and public affairs consultancy as its EU health account ... Coming from a country where market access and negotiations
-
RJW & Partners appoints new director
She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access.
-
M3 appoints Simon Walker as director of education
M3 EU’s CEO Tim Ringrose said: “I’d like to welcome Simon as our Education Director, a key appointment for M3.
More from appointments
Approximately 2 fully matching, plus 58 partially matching documents found.
Latest from PMHub
-
More tell, less sell: HCP-centric comms
2015. 10. DRG Digital. Taking the Pulse Europe 2017: Improving the digital physician experience in EU 5 markets.
-
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
In September 2015, it seemed almost impossible that Jeremy Corbyn could lead the Labour Party to victory; since then, the fallout from the vote to leave the EU and the party’
-
Training the next generation of biotech leaders
In June 2016 the UK voted to leave the EU, prompting a new direction for Britain’ s industrial strategy and a sharp focus on biotech and life sciences – fuelled by leading
-
Behavioural insights to navigate complex healthcare markets
The EU-funded Horizon 2020 Digital Health Research Programme, ProAct2020 (Advancing Proactive Digital Integrated Care) aims to develop and evaluate a digital integrated care system to support older adults living with
-
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE. .
More from PMHub
Approximately 5 fully matching, plus 140 partially matching documents found.
Featured jobs
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Sudler London - Senior Medical Writer
-
Competitive
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Sudler London - Account Director
-
Competitive
Subscribe to our email news alerts
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
